Could cheaper MRI scans spot a dangerous artery disease?

NCT ID NCT05854927

First seen Jan 06, 2026 · Last updated Jun 23, 2026 · Updated 28 times

Summary

This study looks at whether lower-resolution MRI scans can still reliably detect giant cell arteritis, a serious inflammation of arteries that can cause blindness or stroke. Researchers will compare different MRI techniques in 133 adults suspected of having the disease. If lower-resolution scans work well, more hospitals could offer this test, leading to faster diagnosis and treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hôpital Fondation Adolphe de Rothschild

    RECRUITING

    Paris, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

3D T1 MRI sequences with contrast, fat saturation, and black blood

What this could lead to

If successful, this could allow more hospitals to use MRI for diagnosing giant cell arteritis, speeding up treatment and preventing complications.

What could go wrong

This is an early-stage diagnostic study, not a treatment trial. Lower-resolution images may miss subtle signs of inflammation, reducing accuracy.

Conditions

The condition(s) this trial relates to.

Giant Cell Arteritis temporal arteritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.